News Briefs

IvyCap Ventures leads $5m round for Elucidata

Elucidata, a biomedical molecular data company, has secured $5 million in pre-Series A funding.

4 February 2021

Elucidata, a biomedical molecular data company, has secured $5 million in pre-Series A funding. IvyCap Ventures led the round.

Get limited access to our industry news, analysis and data, plus regular email updates

Email address

First name

first name

Last name

last name

Organisation

Country Phone number Job title

Job Title

To register, please review and accept our terms and conditions and privacy notice. I accept: sourceRegistration

Register now